The Health Check-up Market was valued at USD 57.4 billion in 2024, and is projected to reach USD 109.5 billion by 2034, rising at a CAGR of 6.6%, driven by the increasing prevalence of chronic illnesses such as cancer, diabetes, and cardiovascular disorders. As more individuals prioritize preventive care, the demand for routine medical screenings continues to rise, ensuring early detection and improved treatment outcomes. With advancements in diagnostic technologies making screenings more accessible, healthcare providers and insurers are emphasizing the importance of early diagnosis, further propelling market expansion.
As the awareness of proactive health management gains traction, routine check-ups are becoming an integral part of healthcare strategies worldwide. Insurers are increasingly incorporating preventive screenings into coverage plans, encouraging individuals to undergo regular medical evaluations. Governments and private healthcare providers are also launching awareness campaigns and health programs to promote preventive screenings. The convenience of home-based diagnostic services, the growing penetration of telehealth, and the development of AI-driven diagnostic tools are transforming the health check-up landscape, making screenings more efficient and widely available. Additionally, increased employer initiatives supporting employee health and wellness programs are boosting participation in regular health assessments.
The market is segmented by type into general health check-ups, specialized health check-ups, preventive health check-ups, and routine and wellness health check-ups. Among these, the general health check-up segment remains a dominant force in market growth. This segment is expected to expand at a CAGR of 6.5%, reaching USD 41.3 billion by 2034. Routine medical screenings enable early disease detection, reducing the risk of severe health complications and facilitating timely medical interventions. Many health insurance plans now include regular check-ups, ensuring individuals receive essential evaluations to maintain their overall well-being.
Based on test type, the health check-up market comprises complete blood count tests, blood glucose tests, kidney function tests, bone profile tests, electrolyte tests, liver function tests, lipid profile tests, cardiac biomarkers, hormone and vitamin assessments, tumor markers, and other diagnostics. The complete blood count test segment is a key contributor to market expansion, projected to grow at a CAGR of 6.2% and reach USD 24.1 billion by 2034. These tests offer vital insights into blood cell composition, including red and white blood cell counts and platelet levels, enabling healthcare providers to diagnose conditions such as anemia, infections, and blood disorders. Hemoglobin and hematocrit measurements also help assess nutritional status, aiding in the identification of iron deficiency and other health concerns.
The US health check-up market, valued at USD 19.1 billion in 2024, is expected to grow at a CAGR of 5.7% between 2025 and 2034. The rising prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular conditions is driving the need for frequent screenings. Additionally, the aging population requires consistent and comprehensive medical assessments, further fueling the demand for preventive healthcare services. With healthcare providers and insurers actively promoting early intervention, routine medical evaluations in the US are becoming increasingly common. As awareness surrounding proactive health management continues to grow, the health check-up market is poised for sustained expansion over the next decade.
This product will be delivered within 2-4 business days.
As the awareness of proactive health management gains traction, routine check-ups are becoming an integral part of healthcare strategies worldwide. Insurers are increasingly incorporating preventive screenings into coverage plans, encouraging individuals to undergo regular medical evaluations. Governments and private healthcare providers are also launching awareness campaigns and health programs to promote preventive screenings. The convenience of home-based diagnostic services, the growing penetration of telehealth, and the development of AI-driven diagnostic tools are transforming the health check-up landscape, making screenings more efficient and widely available. Additionally, increased employer initiatives supporting employee health and wellness programs are boosting participation in regular health assessments.
The market is segmented by type into general health check-ups, specialized health check-ups, preventive health check-ups, and routine and wellness health check-ups. Among these, the general health check-up segment remains a dominant force in market growth. This segment is expected to expand at a CAGR of 6.5%, reaching USD 41.3 billion by 2034. Routine medical screenings enable early disease detection, reducing the risk of severe health complications and facilitating timely medical interventions. Many health insurance plans now include regular check-ups, ensuring individuals receive essential evaluations to maintain their overall well-being.
Based on test type, the health check-up market comprises complete blood count tests, blood glucose tests, kidney function tests, bone profile tests, electrolyte tests, liver function tests, lipid profile tests, cardiac biomarkers, hormone and vitamin assessments, tumor markers, and other diagnostics. The complete blood count test segment is a key contributor to market expansion, projected to grow at a CAGR of 6.2% and reach USD 24.1 billion by 2034. These tests offer vital insights into blood cell composition, including red and white blood cell counts and platelet levels, enabling healthcare providers to diagnose conditions such as anemia, infections, and blood disorders. Hemoglobin and hematocrit measurements also help assess nutritional status, aiding in the identification of iron deficiency and other health concerns.
The US health check-up market, valued at USD 19.1 billion in 2024, is expected to grow at a CAGR of 5.7% between 2025 and 2034. The rising prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular conditions is driving the need for frequent screenings. Additionally, the aging population requires consistent and comprehensive medical assessments, further fueling the demand for preventive healthcare services. With healthcare providers and insurers actively promoting early intervention, routine medical evaluations in the US are becoming increasingly common. As awareness surrounding proactive health management continues to grow, the health check-up market is poised for sustained expansion over the next decade.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2024
Chapter 5 Market Estimates and Forecast, by Type, 2021-2034 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Test Type, 2021-2034 ($ Mn)
Chapter 7 Market Estimates and Forecast, by Sample Type, 2021-2034 ($ Mn)
Chapter 8 Market Estimates and Forecast, by Panel Type, 2021-2034 ($ Mn)
Chapter 9 Market Estimates and Forecast, by Service Provider, 2021-2034 ($ Mn)
Chapter 10 Market Estimates and Forecast, by Region, 2021-2034 ($ Mn)
Chapter 11 Company Profiles
Companies Mentioned
The companies featured in this Health Check-up market report include:- ARUP Laboratories
- Cerba Healthcare
- eurofins
- Exact Sciences
- GRAIL
- INNOVA
- labcorp
- natera
- OPKO
- Q2 Solutions
- Quest Diagnostics
- Sonic Healthcare
- SYNLAB
- Trinity Biotech
- UNILABS
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 155 |
| Published | February 2025 |
| Forecast Period | 2024 - 2034 |
| Estimated Market Value ( USD | $ 57.4 Billion |
| Forecasted Market Value ( USD | $ 109.5 Billion |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
